Envivo Bio develops a non-invasive device that collects microbiome samples from all regions of the human gastrointestinal tract.
Envivo Bio has raised $973K in total funding. The most recent round was Grant. The last funding was announced in September 2021.
Envivo Bio's investors include National Science Foundation.
Envivo Bio is headquartered in San Francisco, United States.
Envivo Bio develops a non-invasive device that collects microbiome samples from all regions of the human gastrointestinal tract.
Envivo Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Envivo Bio — Funding & Investors." VCBacked, September 10, 2021, https://www.vcbacked.co/company/envivo-bio. Accessed August 13, 2026.
VCBacked. (2021). Envivo Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/envivo-bio
{{cite web |title=Envivo Bio — Funding & Investors |url=https://www.vcbacked.co/company/envivo-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated